AJMC October 11, 2021
Sunita M. Desai, PhD, J. Michael McWilliams, MD, PhD

Participation in the 340B Drug Pricing Program by general acute care hospitals and critical access hospitals has not been associated with increased provision of uncompensated care.

ABSTRACT

Objectives: To evaluate whether hospital entry into the 340B Drug Pricing Program, which entitles eligible hospitals to discounts on drug purchases and intends for hospitals to use associated savings to devote more resources to the care of low-income populations, is associated with changes in hospital provision of uncompensated care.

Study Design: We analyzed secondary data on 340B participation and uncompensated care provision among general acute care hospitals and critical access hospitals from 2003 to 2015. We constructed an annual, hospital-level data set on hospital 340B participation from the Office of Pharmacy Information Systems...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Pharma, Pharma / Biotech, Provider
Nation's 1st double lung-liver transplant performed at Northwestern
Physician Compensation Continues To Decline, Despite A Dire Shortage
340B profit exceeds charity care spending for 85% of disproportionate share hospitals: Report
Ascension continues selling spree
Healthcare security culture steadily improving, but gaps remain

Share This Article